50 related articles for article (PubMed ID: 19135574)
1. Development and verification of mechanistic vaginal absorption and metabolism model to predict systemic exposure after vaginal ring and gel application.
Thakur K; Telaprolu KC; Paterson D; Salem F; Arora S; Polak S
Br J Clin Pharmacol; 2024 Jun; 90(6):1428-1449. PubMed ID: 38450818
[TBL] [Abstract][Full Text] [Related]
2. In vitro inhibition of human papillomavirus following use of a carrageenan-containing vaginal gel.
Novetsky AP; Keller MJ; Gradissimo A; Chen Z; Morgan SL; Xue X; Strickler HD; Fernández-Romero JA; Burk R; Einstein MH
Gynecol Oncol; 2016 Nov; 143(2):313-318. PubMed ID: 27625046
[TBL] [Abstract][Full Text] [Related]
3. Discordance between self-reported contraceptive use and detection of exogenous hormones among Malawian women enrolling in a randomized clinical trial.
Nwaohiri AN; Tang JH; Stanczyk F; Chinula L; Hurst S; Davis NL; Tegha G; Haddad L; Kourtis AP
Contraception; 2018 Apr; 97(4):354-356. PubMed ID: 29246819
[TBL] [Abstract][Full Text] [Related]
4. Commercial hydrogel product for drug delivery based on route of administration.
Raeisi A; Farjadian F
Front Chem; 2024; 12():1336717. PubMed ID: 38476651
[TBL] [Abstract][Full Text] [Related]
5. Priority strategies for India's family planning programme.
Pachauri S
Indian J Med Res; 2014 Nov; 140 Suppl(Suppl 1):S137-46. PubMed ID: 25673535
[TBL] [Abstract][Full Text] [Related]
6. New and emerging contraceptives: a state-of-the-art review.
Bahamondes L; Bahamondes MV
Int J Womens Health; 2014; 6():221-34. PubMed ID: 24570597
[TBL] [Abstract][Full Text] [Related]
7. [Emergency contraception: efficacy difference between levonorgestrel and ulipristal acetate depending on the follicular size at the time of an unprotected sexual intercourse].
Jamin C
Gynecol Obstet Fertil; 2015 Mar; 43(3):242-7. PubMed ID: 25703406
[TBL] [Abstract][Full Text] [Related]
8. Effect of sexual intercourse on the absorption of levonorgestrel after vaginal administration of 0.75 mg in Carraguard gel: a randomized, cross-over, pharmacokinetic study.
Brache V; Croxatto H; Kumar N; Sitruk-Ware R; Cochón L; Schiappacasse V; Sivin I; Muñoz C; Maguire R; Faundes A
Contraception; 2009 Feb; 79(2):150-4. PubMed ID: 19135574
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic study to compare the absorption and tolerability of two doses of levonorgestrel following single vaginal administration of levonorgestrel in Carraguard gel: a new formulation for "dual protection" contraception.
Sitruk-Ware R; Brache V; Maguire R; Croxatto H; Kumar N; Kumar S; Montero JC; Salvatierra AM; Phillips D; Faundes A
Contraception; 2007 Jun; 75(6):454-60. PubMed ID: 17519152
[TBL] [Abstract][Full Text] [Related]
10. The emergency contraceptive drug, levonorgestrel: a review of post-coital oral and peri-coital vaginal administration for prevention of pregnancy.
Sarkar NN
J Obstet Gynaecol; 2011 Nov; 31(8):703-7. PubMed ID: 22085058
[TBL] [Abstract][Full Text] [Related]
11. First week drug concentrations in women with levonorgestrel rod or Norplant capsule implants.
Sivin I; Lähteenmäki P; Mishell DR; Alvarez F; Diaz S; Ranta S; Grozinger C; Lacarra M; Brache V; Pavez M; Nash H; Stern J
Contraception; 1997 Nov; 56(5):317-21. PubMed ID: 9437561
[TBL] [Abstract][Full Text] [Related]
12. Interrelationship of serum levonorgestrel and sex hormone-binding globulin levels following vaginal and oral administration of combined steroid contraceptive tablets.
Abdalla KA; Shabaan MM; Stanczyk FZ
Contraception; 1992 Feb; 45(2):111-8. PubMed ID: 1559334
[TBL] [Abstract][Full Text] [Related]
13. Effect of a single vaginal administration of levonorgestrel in Carraguard gel on the ovulatory process: a potential candidate for "dual protection" emergency contraception.
Brache V; Croxatto H; Sitruk-Ware R; Maguire R; Montero JC; Kumar N; Salvatierra AM; Tejada AS; Cochón L; Forcelledo ML; Lahteenmaki P; Alvarez F; Faundes A
Contraception; 2007 Aug; 76(2):111-6. PubMed ID: 17656180
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
